Effects of Lovastatin Therapy on Susceptibility of LDL to Oxidation During alpha-Tocopherol Supplementation

A randomized, double-masked, crossover clinical trial was carried out to evaluate whether lovastatin therapy (60 mg daily) affects the initiation of oxidation of low density lipoprotein (LDL) in cardiac patients on alpha-tocopherol supplementation therapy (450 IU daily). Twenty-eight men with verifi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 1999-06, Vol.19 (6), p.1541-1548
Hauptverfasser:	Palomaki, Ari, Malminiemi, Kimmo, Malminiemi, Outi, Solakivi, Tiina
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological and medical sciences Copper - pharmacology Cross-Over Studies Double-Blind Method General and cellular metabolism. Vitamins Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Lipoproteins, LDL - metabolism Lovastatin - therapeutic use Male Medical sciences Middle Aged Oxidation-Reduction Pharmacology. Drug treatments Vitamin E - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!